Since HDAC6 inhibitors such as 738 are being explored for their anti-depressive effects in the adult brain [13], there could be a dual advantage in using HDAC6 inhibitors to target rapidly dividing tumor cells in glioma patients battling depression, which often accompanies this cancer [41]. Here, HDAC6 is linked to depressive disorder.